Effect of Delivery Route on the Pharmacokinetics of Sufentanil NanoTab(R) in Healthy Subjects

Trial Profile

Effect of Delivery Route on the Pharmacokinetics of Sufentanil NanoTab(R) in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Oct 2015

At a glance

  • Drugs Sufentanil (Primary) ; Sufentanil (Primary) ; Sufentanil (Primary) ; Sufentanil (Primary)
  • Indications Acute pain; Cancer pain; Postoperative pain
  • Focus Pharmacokinetics
  • Sponsors AcelRx Pharmaceuticals
  • Most Recent Events

    • 02 May 2013 Results presented at American Society of Regional Anesthesia and Pain Medicine (ASRA) meeting, according to AcelRx Pharmaceuticals media release.
    • 09 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top